Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association between APOL1 risk variants and progression from infection to sepsis

View ORCID ProfileLan Jiang, Ge Liu, Annette Oeser, Andrea Ihegword, Alyson L. Dickson, Laura L. Daniel, Adriana M Hung, Nancy J. Cox, Cecilia P. Chung, Wei-Qi Wei, C. Michael Stein, View ORCID ProfileQiPing Feng
doi: https://doi.org/10.1101/2023.01.27.23284540
Lan Jiang
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lan Jiang
Ge Liu
2Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Oeser
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Ihegword
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyson L. Dickson
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura L. Daniel
4Division of Rheumatology, Department of Medicine, University of Miami and Miami VA hospital, Miami, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana M Hung
5Tennessee Valley Healthcare System, Nashville Campus, Nashville, TN
6Division of Nephrology & Hypertension, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy J. Cox
7Vanderbilt Genetics Institute, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia P. Chung
4Division of Rheumatology, Department of Medicine, University of Miami and Miami VA hospital, Miami, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei-Qi Wei
2Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Michael Stein
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
8Department of Pharmacology, Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
QiPing Feng
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
7Vanderbilt Genetics Institute, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for QiPing Feng
  • For correspondence: qiping.feng{at}vumc.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Two risk variants in the apolipoprotein L1 gene (APOL1) have been associated with increased susceptibility to sepsis in Black patients. However, it remains unclear whether APOL1 high-risk genotypes are associated with either progression from infection to sepsis or sepsis-related phenotypes, independent of their association with severe renal disease.

Objective To examine the association between APOL1 high-risk genotypes and the risk of progression from infection to sepsis and sepsis-related phenotypes.

Design, setting, and participants A retrospective cohort study of 2,242 Black patients hospitalized with an infection.

Exposures Carriage of APOL1 high-risk genotypes.

Main outcomes and measures The primary outcome was sepsis; secondary outcomes were death and organ failure related to sepsis.

Results Of 2,242 Black patients hospitalized with infections, 565 developed sepsis. Patients with high-risk APOL1 genotypes had a significantly increased risk of sepsis (odds ratio [OR]=1.29 [95% CI, 1.00–1.67; p=0.047]); however, this association was not significant after adjustment for pre-existing severe renal disease (OR=1.14 [95% CI, 0.88-1.48; p=0.33]), nor after exclusion of those patients with pre-existing severe renal disease (OR=0.99 [95% CI, 0.70-1.39; p=0.95]. APOL1 high-risk genotypes were significantly associated with the renal dysfunction component of the Sepsis-3 criteria (OR=1.64 [95% CI, 1.21–2.22; p=0.001], but not with other sepsis-related organ dysfunction or death. The association between high-risk APOL1 genotypes and sepsis-related renal dysfunction was markedly attenuated by adjusting for pre-existing severe renal disease (OR=1.36 [95% CI, 1.00–1.86; p=0.05]) and was nullified after exclusion of patients with pre-existing severe renal disease (OR=1.16 [95% CI, 0.74–1.81; p=0.52]).

Conclusion and relevance APOL1 high-risk genotypes were associated with an increased risk of sepsis; however, this increased risk was attributable predominantly to pre-existing renal disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by GM120523 (Q.F.), R01HL163854 (Q.F.), R35GM131770 (C.M.S.), HL133786 (W.Q.W.) and Vanderbilt Faculty Research Scholar Fund (Q.F.). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the CTSA grant UL1TR0004from NCATS/NIH. Additional funding provided by the NIH through grants P50GM115305 and U19HL065962. The authors wish to acknowledge the expert technical support of the VANTAGE and VANGARD core facilities, supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA068485) and Vanderbilt Vision Center (P30 EY08126). Role of the Funder/Sponsor: The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Contributor Statement: L.J., G.L., A.O., A.I., A.L.D., L.L.D., C.P.C., N.C, W.Q.W., C.M.S. and Q.F. wrote the manuscript; L.J., C.M.S., and Q.F. designed the research; L.J., G.L., A.O., A.I., A.L.D., L.L.D., C.P.C., W.Q.W., C.M.S. and Q.F. performed the research; L.J., G.L., C.M.S and Q.F. analyzed the data.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The authors declared no competing interests for this work.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 28, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Association between APOL1 risk variants and progression from infection to sepsis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Association between APOL1 risk variants and progression from infection to sepsis
Lan Jiang, Ge Liu, Annette Oeser, Andrea Ihegword, Alyson L. Dickson, Laura L. Daniel, Adriana M Hung, Nancy J. Cox, Cecilia P. Chung, Wei-Qi Wei, C. Michael Stein, QiPing Feng
medRxiv 2023.01.27.23284540; doi: https://doi.org/10.1101/2023.01.27.23284540
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Association between APOL1 risk variants and progression from infection to sepsis
Lan Jiang, Ge Liu, Annette Oeser, Andrea Ihegword, Alyson L. Dickson, Laura L. Daniel, Adriana M Hung, Nancy J. Cox, Cecilia P. Chung, Wei-Qi Wei, C. Michael Stein, QiPing Feng
medRxiv 2023.01.27.23284540; doi: https://doi.org/10.1101/2023.01.27.23284540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3290)
  • Dentistry and Oral Medicine (364)
  • Dermatology (278)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1170)
  • Epidemiology (13368)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (782)
  • Health Informatics (3264)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (430)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14624)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (476)
  • Medical Ethics (127)
  • Nephrology (522)
  • Neurology (4922)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2522)
  • Ophthalmology (723)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4208)
  • Public and Global Health (7501)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1012)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)